Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive
A federal appeals court said the U.S. government was right to challenge Illumina’s purchase of cancer-test developer Grail, but still...
Biotechnology Services
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
Updated Oct. 23, 2023 6:55 am ETRoche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant...
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
Illumina Names Jacob Thaysen as New CEO
Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight...
Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact...
FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source...
Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
After Illumina CEO’s Fall, Other Executives Are Expected to Take Hard Look at Deals
ShareListen(2 min) Source link
Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight
Activist investor Carl Icahn has signaled he wants former CEO Jay Flatley to return to gene-sequencing test maker. Source link
Blood-Test Customers Mistakenly Told They May Have Cancer
Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch. Source link
U.S. Makes New Push in Trade Fight With Mexico Over GMO Corn
The U.S. stepped up its efforts to get Mexico to ease its restrictions on genetically modified corn, after more than...
FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics
ShareListen(2 min) Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Moderna’s Earnings, Revenue Fall on Fewer Covid Vaccine Sales
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
U.S. Appeals Court Sides With Drugmakers on Discount Program
BusinessHealth CareHealthDrugmakers can limit shipments to hospitals and clinics of drugs discounted under federal program, court rules in loss for...
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
The company said it would apply in coming months for U.S. regulatory approval. Source link
